Photobiomodulation for Degenerative Diseases: An Overview and Perspectives

Abstract

Background:

Photobiomodulation (PBM) is a well-established, noninvasive therapeutic modality supported by a robust scientific foundation and extensive case studies.

Objectives:

However, in recent years, researchers have reported that low-intensity light could also help slow down degenerative processes resulting from unbalanced or epigenetically exacerbated aging.

Methods:

We present data that support the use of PBM in addressing some of the primary degenerative diseases that significantly impact patients’ quality of life.

Results:

Chronic diseases highlight the importance of emerging approaches utilizing low-power light sources, whether applied locally, systemically, or remotely.

Conclusions:

We conclude that PBM holds significant promise for patients suffering from chronic and debilitating conditions, offering potential therapeutic benefits. As the science of biophotonic continues to evolve, further advancements in light-based therapies are expected to enhance healing processes and improve the quality of life for patients worldwide. The growing body of evidence suggests that PBM is well-prepared to face the challenges imposed by degenerative diseases.